Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Precision oncology industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product type trends
2.1.4 Cancer type trends
2.1.5 End-user trends
Chapter 3 Precision Oncology Market Insights
3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of cancer
3.2.1.2 Advancement in technologies
3.2.1.3 Increasing demand for personalized medicine
3.2.1.4 Rising government initiatives and funding
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of precision medicine
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.3.1 By product type
3.3.2 By cancer type
3.3.3 By end-user
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022
Chapter 5 Precision Oncology Market Estimates and Forecast, By Product Type, 2018-2032 (USD Million)
5.1 Key trends, by product type
5.2 Therapeutics
5.3 Diagnostics
5.3.1 Biomarker based tests
5.3.2 Genetic tests
5.3.3 Other diagnostics
Chapter 6 Precision Oncology Market Estimates and Forecast, By Cancer Type, 2018-2032 (USD Million)
6.1 Key trends, by cancer type
6.2 Breast cancer
6.3 Lung cancer
6.4 Colorectal cancer
6.5 Prostate cancer
6.6 Skin cancer
6.7 Stomach cancer
6.8 Other cancer types
Chapter 7 Precision Oncology Market Estimates and Forecast, By End-user, 2018-2032 (USD Million)
7.1 Key trends, by application
7.2 Diagnostic centers
7.3 Hospitals
7.4 Research & academic institutes
7.5 Other end-users
Chapter 8 Precision Oncology Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Thermo Fisher Scientific Inc.
9.2 Invitae Corporation
9.3 Illumina, Inc.
9.4 Qiagen N.V.
9.5 Novartis AG
9.6 Erasca Inc
9.7 F. Hoffmann-La Roche AG
9.8 Rain Therapeutics Inc
9.9 Agendia Inc
9.10 Strata Oncology, Inc
